Nordstrom is finally going private in a $6.25 billion dealByFrancisco VelasquezPublishedDecember 23, 2024
AI ignited a private market boom. Now wealthy investors want moreByRocio FabbroUpdatedJanuary 9, 2025
What's ahead for the markets in 2025, according to expertsByVinamrata ChaturvediPublishedDecember 16, 2024
A major food company is adding Ozempic-friendly badges to some productsByBruce GilUpdatedDecember 13, 2024
What can't weight-loss meds do? Eli Lilly is going to test obesity drugs as a treatment for addictionByBruce GilUpdatedDecember 11, 2024
Apple, Nvidia, and Microsoft are America's best-managed companies right now, report saysByRocio FabbroPublishedDecember 9, 2024
Ozempic and other weight loss drugs could be making people drink less, study saysByBruce GilUpdatedDecember 2, 2024
Intel just ousted CEO Pat Gelsinger as it struggles to compete in the AI eraByRocio FabbroUpdatedDecember 2, 2024
Walmart just became the biggest company to roll back its DEI initiativesByWilliam GavinUpdatedNovember 26, 2024
Stock market risks, Bitcoin breaks through, and Trump Media's crypto play: Markets news roundupPublishedNovember 23, 2024
The S&P 500 is about to have a big 2025, Goldman Sachs says — even without the 'Magnificent 7'ByVinamrata ChaturvediUpdatedNovember 19, 2024
Mergers and acquisitions could kick into high gear under TrumpByRocio FabbroPublishedNovember 18, 2024
Donald Trump's election win is a 'regulatory game changer' for banks, Wells Fargo saysByRocio FabbroUpdatedNovember 6, 2024
Disney needs a new CEO. Meet the Wall Street banker in charge of replacing Bob IgerByBruce GilUpdatedOctober 22, 2024
Do people trust AI with their money? Here's what research showsByGertjan Verdickt / The ConversationPublishedOctober 20, 2024
Ozempic and other weight loss drugs could help treat alcohol and drug addiction, study saysByBruce GilPublishedOctober 17, 2024
